Menu
GeneBe

MYO7A

myosin VIIA, the group of FERM domain containing|Myosin heavy chains, class VII|A-kinase anchoring proteins

Basic information

Region (hg38): 11:77128245-77215241

Previous symbols: [ "USH1B", "DFNB2", "DFNA11" ]

Links

ENSG00000137474NCBI:4647OMIM:276903HGNC:7606Uniprot:Q13402AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • autosomal dominant nonsyndromic hearing loss 11 (Strong), mode of inheritance: AD
  • autosomal recessive nonsyndromic hearing loss 2 (Limited), mode of inheritance: AR
  • Usher syndrome type 1 (Strong), mode of inheritance: AR
  • autosomal dominant nonsyndromic hearing loss 11 (Moderate), mode of inheritance: AD
  • autosomal dominant nonsyndromic hearing loss (Supportive), mode of inheritance: AD
  • hearing loss, autosomal recessive (Supportive), mode of inheritance: AR
  • Usher syndrome type 1 (Supportive), mode of inheritance: AR
  • Usher syndrome type 2 (Supportive), mode of inheritance: AR
  • autosomal dominant nonsyndromic hearing loss 11 (Strong), mode of inheritance: AD
  • autosomal recessive nonsyndromic hearing loss 2 (Moderate), mode of inheritance: AR
  • Usher syndrome type 1B (Definitive), mode of inheritance: AR
  • autosomal recessive nonsyndromic hearing loss 2 (Definitive), mode of inheritance: AR
  • autosomal recessive nonsyndromic hearing loss 2 (Strong), mode of inheritance: AR
  • Usher syndrome type 1B (Strong), mode of inheritance: AR
  • Usher syndrome type 1 (Definitive), mode of inheritance: AR
  • nonsyndromic genetic hearing loss (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Deafness, autosomal recessive 2; Usher syndrome, type IARAudiologic/OtolaryngologicEarly recognition and treatment of hearing impairment may improve outcomes, including speech and language developmentAudiologic/Otolaryngologic; Ophthalmologic7951250; 8776602; 9171832; 7870171; 9171833; 11391666; 11889386; 15221449; 18181211; 20132242; 21436283; 21150918; 23226338
The timing of onset has been reported as highly variable, though heterozygous variants appear to result in postlingual onset

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MYO7A gene.

  • not provided (3332 variants)
  • Usher syndrome type 1B (526 variants)
  • Usher syndrome type 1 (466 variants)
  • Autosomal recessive nonsyndromic hearing loss 2 (387 variants)
  • not specified (374 variants)
  • Autosomal dominant nonsyndromic hearing loss 11 (333 variants)
  • Usher syndrome type 1;Autosomal recessive nonsyndromic hearing loss 2 (140 variants)
  • Rare genetic deafness (101 variants)
  • Inborn genetic diseases (90 variants)
  • Autosomal recessive nonsyndromic hearing loss 2;Usher syndrome type 1 (85 variants)
  • Usher syndrome (65 variants)
  • Retinal dystrophy (51 variants)
  • Autosomal dominant nonsyndromic hearing loss 11;Autosomal recessive nonsyndromic hearing loss 2;Usher syndrome type 1 (31 variants)
  • Autosomal dominant nonsyndromic hearing loss 11;Usher syndrome type 1;Autosomal recessive nonsyndromic hearing loss 2 (27 variants)
  • MYO7A-related condition (21 variants)
  • Hearing loss, autosomal recessive (20 variants)
  • Hearing impairment (18 variants)
  • MYO7A-Related Disorders (15 variants)
  • Usher syndrome type 1;Autosomal dominant nonsyndromic hearing loss 11;Autosomal recessive nonsyndromic hearing loss 2 (14 variants)
  • Usher syndrome type 1;Autosomal recessive nonsyndromic hearing loss 2;Autosomal dominant nonsyndromic hearing loss 11 (9 variants)
  • Nonsyndromic genetic hearing loss (9 variants)
  • Meniere disease (9 variants)
  • Ear malformation (7 variants)
  • Autosomal recessive nonsyndromic hearing loss 2;Usher syndrome type 1;Autosomal dominant nonsyndromic hearing loss 11 (6 variants)
  • Deafness (4 variants)
  • Auditory neuropathy (3 variants)
  • Retinitis pigmentosa (3 variants)
  • Autosomal recessive nonsyndromic hearing loss 2;Autosomal dominant nonsyndromic hearing loss 11;Usher syndrome type 1 (3 variants)
  • Nonsyndromic Hearing Loss, Dominant (3 variants)
  • Retinitis pigmentosa-deafness syndrome (3 variants)
  • Usher syndrome type 2 (3 variants)
  • Nonsyndromic Hearing Loss, Recessive (3 variants)
  • See cases (2 variants)
  • Childhood onset hearing loss (2 variants)
  • - (2 variants)
  • Hearing loss (2 variants)
  • Bilateral sensorineural hearing impairment (1 variants)
  • Sensorineural hearing loss disorder (1 variants)
  • Sensorineural hearing loss disorder;Microcephaly;Global developmental delay;Short stature (1 variants)
  • MYO7A-related disorder (1 variants)
  • Cohen syndrome (1 variants)
  • Sensorineural hearing loss disorder;Global developmental delay;Hepatomegaly;Seizure;Hypoglycemia (1 variants)
  • Pendred syndrome (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MYO7A gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
15
clinvar
919
clinvar
8
clinvar
942
missense
28
clinvar
93
clinvar
896
clinvar
41
clinvar
3
clinvar
1061
nonsense
100
clinvar
97
clinvar
3
clinvar
200
start loss
2
clinvar
1
clinvar
3
frameshift
123
clinvar
68
clinvar
4
clinvar
195
inframe indel
4
clinvar
3
clinvar
24
clinvar
1
clinvar
32
splice donor/acceptor (+/-2bp)
32
clinvar
76
clinvar
2
clinvar
1
clinvar
111
splice region
9
63
170
6
248
non coding
1
clinvar
32
clinvar
410
clinvar
151
clinvar
594
Total 287 340 977 1372 162

Highest pathogenic variant AF is 0.000105

Variants in MYO7A

This is a list of pathogenic ClinVar variants found in the MYO7A region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
11-77128325-A-G Autosomal dominant nonsyndromic hearing loss 11 • Usher syndrome type 1 • Autosomal recessive nonsyndromic hearing loss 2 Conflicting classifications of pathogenicity (Jan 12, 2018)306146
11-77128340-C-T Autosomal recessive nonsyndromic hearing loss 2 • Usher syndrome type 1 • Autosomal dominant nonsyndromic hearing loss 11 Uncertain significance (Jan 13, 2018)306147
11-77128366-C-T Autosomal dominant nonsyndromic hearing loss 11 • Usher syndrome type 1 • Autosomal recessive nonsyndromic hearing loss 2 Uncertain significance (Jan 13, 2018)306148
11-77128376-G-A Retinitis pigmentosa-deafness syndrome • Nonsyndromic Hearing Loss, Recessive • Nonsyndromic Hearing Loss, Dominant Uncertain significance (Jun 14, 2016)306149
11-77128382-G-A Autosomal recessive nonsyndromic hearing loss 2 • Autosomal dominant nonsyndromic hearing loss 11 • Usher syndrome type 1 Conflicting classifications of pathogenicity (Jan 13, 2018)306150
11-77128484-C-G Autosomal dominant nonsyndromic hearing loss 11 • Usher syndrome type 1 • Autosomal recessive nonsyndromic hearing loss 2 Uncertain significance (Apr 27, 2017)884039
11-77130587-A-G Usher syndrome type 1B Uncertain significance (Aug 17, 2020)1215568
11-77130615-G-A Usher syndrome type 1 • Autosomal recessive nonsyndromic hearing loss 2 • Autosomal dominant nonsyndromic hearing loss 11 Uncertain significance (Jan 12, 2018)306151
11-77130635-A-G Rare genetic deafness • Usher syndrome type 1 • Usher syndrome Pathogenic/Likely pathogenic (Oct 27, 2023)179567
11-77130637-G-A Autosomal recessive nonsyndromic hearing loss 2;Usher syndrome type 1 • Meniere disease • Usher syndrome type 1B Pathogenic/Likely pathogenic (Dec 17, 2023)553231
11-77130647-C-T Pathogenic (Sep 22, 2019)936103
11-77130653-G-A Pathogenic (Jan 25, 2024)2711287
11-77130654-T-A Usher syndrome type 1;Autosomal recessive nonsyndromic hearing loss 2 Likely pathogenic (May 26, 2021)558377
11-77130654-T-C Pathogenic (Jan 11, 2023)2827733
11-77130659-G-A Likely benign (Apr 30, 2023)2979564
11-77130667-C-T Likely benign (Dec 19, 2022)2993831
11-77142675-G-A Likely benign (Jun 16, 2018)677340
11-77142691-ACT-A Likely benign (Feb 04, 2023)2178068
11-77142692-C-A Likely benign (Mar 10, 2023)2975089
11-77142692-C-T Likely benign (Jan 04, 2024)1585118
11-77142694-C-G Likely benign (Dec 17, 2023)2885687
11-77142696-C-T Likely benign (Jan 31, 2024)1591399
11-77142700-C-A Uncertain significance (Feb 09, 2022)998593
11-77142700-C-T Autosomal dominant nonsyndromic hearing loss 11 • Usher syndrome type 1 • Autosomal recessive nonsyndromic hearing loss 2 • Usher syndrome type 1B Conflicting classifications of pathogenicity (Jan 29, 2024)748880
11-77142701-G-A Likely benign (Dec 26, 2023)728593

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MYO7Aprotein_codingprotein_codingENST00000409709 4886975
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.61e-380.61012497701991251760.000795
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.0712421.35e+30.9180.000088414374
Missense in Polyphen552609.140.90626320
Synonymous-0.7495855621.040.00003844197
Loss of Function2.89771100.7020.000005271285

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001790.00155
Ashkenazi Jewish0.0008040.000795
East Asian0.0004550.000437
Finnish0.001290.00125
European (Non-Finnish)0.0007320.000698
Middle Eastern0.0004550.000437
South Asian0.001110.00108
Other0.0008450.000822

dbNSFP

Source: dbNSFP

Function
FUNCTION: Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Their highly divergent tails bind to membranous compartments, which are then moved relative to actin filaments. In the retina, plays an important role in the renewal of the outer photoreceptor disks. Plays an important role in the distribution and migration of retinal pigment epithelial (RPE) melanosomes and phagosomes, and in the regulation of opsin transport in retinal photoreceptors. In the inner ear, plays an important role in differentiation, morphogenesis and organization of cochlear hair cell bundles. Involved in hair-cell vesicle trafficking of aminoglycosides, which are known to induce ototoxicity (By similarity). Motor protein that is a part of the functional network formed by USH1C, USH1G, CDH23 and MYO7A that mediates mechanotransduction in cochlear hair cells. Required for normal hearing. {ECO:0000250, ECO:0000269|PubMed:19643958, ECO:0000269|PubMed:21493626, ECO:0000269|PubMed:21687988, ECO:0000269|PubMed:21709241}.;
Disease
DISEASE: Usher syndrome 1B (USH1B) [MIM:276900]: USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH1 is characterized by profound congenital sensorineural deafness, absent vestibular function and prepubertal onset of progressive retinitis pigmentosa leading to blindness. {ECO:0000269|PubMed:10094549, ECO:0000269|PubMed:10364543, ECO:0000269|PubMed:10447383, ECO:0000269|PubMed:10930322, ECO:0000269|PubMed:12112664, ECO:0000269|PubMed:15660226, ECO:0000269|PubMed:16679490, ECO:0000269|PubMed:23559863, ECO:0000269|PubMed:24831256, ECO:0000269|PubMed:25798947, ECO:0000269|PubMed:7870171, ECO:0000269|PubMed:8900236, ECO:0000269|PubMed:9002678, ECO:0000269|PubMed:9382091, ECO:0000269|PubMed:9718356}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Deafness, autosomal recessive, 2 (DFNB2) [MIM:600060]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:28281779, ECO:0000269|PubMed:9171832, ECO:0000269|PubMed:9171833}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Deafness, autosomal dominant, 11 (DFNA11) [MIM:601317]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA11 is characterized by onset after complete speech acquisition and subsequent gradual progression. {ECO:0000269|PubMed:15121790, ECO:0000269|PubMed:15221449, ECO:0000269|PubMed:15300860, ECO:0000269|PubMed:9354784}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Signaling by GPCR;Signal Transduction;The canonical retinoid cycle in rods (twilight vision);G alpha (i) signalling events;Visual phototransduction;GPCR downstream signalling (Consensus)

Recessive Scores

pRec
0.339

Intolerance Scores

loftool
0.0260
rvis_EVS
-2.51
rvis_percentile_EVS
0.93

Haploinsufficiency Scores

pHI
0.121
hipred
N
hipred_score
0.289
ghis
0.490

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.851

Gene Damage Prediction

AllRecessiveDominant
MendelianHighMediumHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Myo7a
Phenotype
growth/size/body region phenotype; homeostasis/metabolism phenotype; cellular phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); pigmentation phenotype; hematopoietic system phenotype; reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; vision/eye phenotype;

Zebrafish Information Network

Gene name
myo7aa
Affected structure
auditory receptor cell
Phenotype tag
abnormal
Phenotype quality
splayed

Gene ontology

Biological process
phagolysosome assembly;intracellular protein transport;lysosome organization;visual perception;sensory perception of sound;actin filament-based movement;cellular protein localization;eye photoreceptor cell development;mechanoreceptor differentiation;post-embryonic animal organ morphogenesis;sensory perception of light stimulus;equilibrioception;pigment granule transport;auditory receptor cell stereocilium organization
Cellular component
photoreceptor outer segment;photoreceptor inner segment;cytoplasm;lysosomal membrane;cytosol;microvillus;cell cortex;apical plasma membrane;myosin VII complex;photoreceptor connecting cilium;stereocilium;melanosome;synapse;stereocilium base;upper tip-link density
Molecular function
microfilament motor activity;protein binding;calmodulin binding;ATP binding;protein domain specific binding;spectrin binding;actin-dependent ATPase activity;protein homodimerization activity;ADP binding;protein N-terminus binding;actin filament binding